EPHA2 and breast cancer: Based on the assumption that EPHA2-ephrin-A1 interaction downregulates BC cell growth and survival, Noblitt et al. engineered ephrin-A1-expressing HAd-based vectors to infect MDA-MB-231 human BC cells overexpressing EPHA2.